26 results
424B3
QTTB
Q32 Bio Inc.
29 Apr 24
Prospectus supplement
5:10pm
as the chair of the audit committee and is a financial expert under the rules of the SEC. To qualify as independent to serve on our audit committee
8-K
EX-10.8
QTTB
Q32 Bio Inc.
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
of all documents that may be introduced at the arbitration or considered or used by a party’s witness or expert. The arbitrator’s decision and award shall … at the arbitration and a copy of all documents that may be introduced at the arbitration or considered or used by a party’s witness or expert. The arbitrator’s
8-K
EX-10.7
QTTB
Q32 Bio Inc.
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
Enterprise by an independent certified public accountant or by an appraiser or other expert selected with reasonable care by the Company or any other
8-K
0fmiqeq9zdkaif0tpfuh
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
8-K
EX-10.6
0pwxzar 24lie
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
424B3
h2g9e09nxxenovu771
13 Mar 24
Prospectus supplement
1:36pm
S-4
EX-10.37
qfmhwli
15 Dec 23
Registration of securities issued in business combination transactions
7:15pm
S-4
EX-99.3
ui6bpbc1q5vwvus
15 Dec 23
Registration of securities issued in business combination transactions
7:15pm
424B5
c2vtajl 5mu470m2hw
8 Apr 21
Prospectus supplement for primary offering
8:38am
424B5
tfl91 q6uun1dis3qr
7 Apr 21
Prospectus supplement for primary offering
12:00am